Search Results 281-290 of 852 for NDC

  1. Dr. Narr Archives - Mayo Clinic News Network

  2. Christina A. von Roemeling1, Laura Marlow1, Robert C. Smallridge2, John A. Copland1

    Introduction: Anaplastic Thyroid Carcinomas (ATC) are aggressive, undifferentiated tumors for which there currently is no cure. Although ATC accounts for a ...

  3. Safety And Tolerability Of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) In Real World Scenarios Of Patients With Chronic Kidney Disease (CKD) - Mayo Clinic

    Protocol includes a single treatment with intravenously-delivered allogeneic bone marrow-derived mesenchymal stem cells (BM-MSCs) infusion. Individuals will ...

  4. Study Of Trastuzumab Deruxtecan, Pembrolizumab, And Platinum-based Chemotherapy In First-line HER2 Overexpressing Non-small Cell Lung Cancer - Mayo Clinic

    Study Of Trastuzumab Deruxtecan, Pembrolizumab, And Platinum-based Chemotherapy In First-line HER2 Overexpressing Non-small Cell Lung Cancer · Overview.

  5. Publications - Dan P. Larson, M.D. - Mayo Clinic

    Dalland JC, Dasari S, Theis JD, Howard MT, Vrana JA, Dao LN, Chiu A, Rech KL, Larson DP, Nasr SH, Grogan M, Dispenzieri A, McPhail ED.

  6. Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID) - Mayo Clinic

    Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID).

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Selinexor in Advanced Liposarcoma - Clinical Trials

    This is a randomized, multicenter, double-blind, placebo-controlled, Phase 2-3 study of patients diagnosed with advanced unresectable dedifferentiated ...

  9. Digital Stories and Psychosocial Wellbeing in Stem Cell Transplant Patients - Mayo Clinic

    Participants, recruited from the Mayo Clinic Arizona Cancer Center, will be randomly assigned to one of two conditions: the DS intervention or the IC video ...

  10. Publications - Devin Oglesbee, Ph.D. - Mayo Clinic

    Publications · Khoja IT, Peck DS, Gavrilov DK, McPheron MA, Oglesbee D, Bentz Pino G, Sapp KL, Schultz MJ, Studinski Jones AL, White AL, Tortorelli S, Matern D, ...